Yes, adding amlodipine 5 mg once daily to losartan 50 mg is highly appropriate and guideline-recommended for your patient.
Your patient has uncontrolled hypertension (BP 150s/90s) on losartan monotherapy, and current guidelines strongly recommend initiating two-drug combination therapy—specifically a RAS blocker (like losartan) plus a calcium channel blocker (like amlodipine)—for most patients with confirmed hypertension ≥140/90 mmHg 1, 2.
Why This Combination Is Recommended
The 2024 ESC and 2025 AHA/ACC guidelines explicitly state that combination BP-lowering treatment is recommended for most patients with confirmed hypertension (BP ≥140/90 mmHg) as initial therapy, with preferred combinations being a RAS blocker (ACE inhibitor or ARB) with a dihydropyridine calcium channel blocker 1. Your patient's BP of 150s/90s clearly exceeds this threshold.
Key Supporting Evidence:
- Guideline-directed therapy: Both major guidelines identify ARB + CCB as a first-line preferred combination 1, 2
- Proven efficacy: The losartan 50 mg + amlodipine 5 mg combination produces significantly greater BP reductions than either monotherapy alone—approximately 8-9 mmHg additional systolic and 5-6 mmHg diastolic reduction 3, 4
- Safety profile: This combination is well-tolerated with comparable or superior tolerability to monotherapy 5, 6
Dosing Considerations
Start with amlodipine 5 mg once daily as recommended by FDA labeling 7. This is the appropriate initial dose for combination therapy. The losartan dose of 50 mg is already at the standard starting level 8.
Treatment Algorithm Moving Forward:
- Add amlodipine 5 mg now to the existing losartan 50 mg
- Reassess BP in 2-4 weeks (guidelines recommend 7-14 days between titrations, but clinical assessment frequency should be individualized) 7
- If BP remains >130/80 mmHg after 4-8 weeks:
- If still uncontrolled on maximal two-drug therapy, add a thiazide-like diuretic (chlorthalidone or indapamide preferred) to create a three-drug regimen 1, 2
Target Blood Pressure
Aim for systolic BP 120-129 mmHg if well-tolerated 1. The guidelines have moved away from the older <140/90 mmHg target toward more intensive control (120-129 mmHg systolic) to reduce cardiovascular risk, provided treatment is tolerated.
Important Clinical Considerations
Single-Pill Combination Preferred
If available, use a fixed-dose single-pill combination of amlodipine/losartan rather than separate pills 1. This improves adherence significantly, though separate pills are acceptable if fixed-dose combinations aren't accessible.
Common Pitfall to Avoid
Peripheral edema is the most common side effect of amlodipine (occurs in ~10% of patients on monotherapy) 6. However, when combined with an ARB like losartan, the incidence of edema is actually reduced compared to amlodipine alone—only 1% in combination therapy 6. The ARB appears to have a protective effect against CCB-induced edema.
Timing of Administration
Take medications at the most convenient time for the patient to establish a habitual pattern and improve adherence 1. There's no significant difference in efficacy between morning and evening dosing for this combination.
What This Means for Your Patient
At 61 years old with essential hypertension, your patient needs more aggressive BP control. Research specifically demonstrates that in patients who fail to achieve BP <90 mmHg diastolic on losartan 50 mg alone, adding amlodipine 5 mg results in 27.5% achieving BP goal versus only 12.5% with placebo (OR 2.73, p<0.001) 4. The combination produces mean reductions of 8.1/5.4 mmHg beyond what losartan alone achieves 4.
This is not just reasonable—it's the evidence-based standard of care for uncontrolled hypertension on monotherapy.